Meningitis UK drafts in Tetra Strategy for vaccine campaign

Tetra Strategy is working on a public affairs drive intended to build a case for the NHS to adopt the first licensed vaccine for meningitis B.

Vaccine brief: Meningitis B
Vaccine brief: Meningitis B

Meningitis UK, a charity that funds vaccine development, has engaged the agency ahead of a key decision as to whether Novartis’ Bexsero vaccine should be included on the NHS’ childhood immunisation programme.

The assessment will be made by the Joint Committee on Vaccination and Immunisation in June.

Tetra was engaged after a closed pitch.

On average, meningitis B affects 1,870 people each year, of whom ten per cent will die and a third will be left with life-changing after-effects. 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in